Edible Garden Ag Inc EDBL
We take great care to ensure that the data presented and summarized in this overview for Edible Garden AG Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EDBL
View allLatest Institutional Activity in EDBL
Top Purchases
Top Sells
About EDBL
Edible Garden AG Incorporated and its subsidiaries operate as a controlled environment agriculture farming company. It offers various products, including individually potted, live herbs, cut single-herb clamshells, specialty herb items, various types of lettuce, hydro basil, bulk basil, and vegan protein powder. The company sells its products to various regional and national supermarkets. Edible Garden AG Incorporated was founded in 2020 and is based in Belvidere, New Jersey.
Insider Transactions at EDBL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2024
|
Ubs Group Ag > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,056
-9.48%
|
$180,336
$6.1 P/Share
|
|
Apr 25
2024
|
Ubs Group Ag > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,005
+0.47%
|
$6,030
$6.1 P/Share
|
|
Apr 24
2024
|
Ubs Group Ag > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
106
-0.16%
|
$636
$6.25 P/Share
|
|
Jun 02
2023
|
Pamela Don Aroma Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$1,000
$1.51 P/Share
|
|
May 18
2023
|
James E. Kras President and CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+2.07%
|
$1,000
$1.68 P/Share
|
|
Apr 03
2023
|
Deborah K. Pawlowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,397
+50.0%
|
-
|
|
Sep 14
2022
|
Michael C James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.06%
|
$0
$0.88 P/Share
|
|
Sep 14
2022
|
James E. Kras President and CEO |
BUY
Open market or private purchase
|
Direct |
875
+0.06%
|
$0
$0.94 P/Share
|
|
Sep 08
2022
|
Michael C James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
6,070
+0.38%
|
$0
$0.84 P/Share
|
|
Aug 30
2022
|
Ryan L. Rogers Director |
BUY
Grant, award, or other acquisition
|
Direct |
83,790
+50.0%
|
-
|
|
Aug 30
2022
|
Mathew J. Mc Connell Director |
BUY
Grant, award, or other acquisition
|
Direct |
83,790
+50.0%
|
-
|
|
May 19
2022
|
James E. Kras President and CEO |
BUY
Open market or private purchase
|
Direct |
900
+0.06%
|
$900
$1.67 P/Share
|
|
May 13
2022
|
James E. Kras President and CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$150
$1.8 P/Share
|
|
May 09
2022
|
Michael C James Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
284,930
+1.61%
|
$1,139,720
$4.62 P/Share
|
|
May 09
2022
|
James E. Kras President and CEO |
BUY
Conversion of derivative security
|
Direct |
6,015
+0.43%
|
$24,060
$4.62 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 1.01K shares |
|---|
| Open market or private sale | 30.2K shares |
|---|